Publication: Engineered sulfated polysaccharides for biomedical applications
dc.contributor.coauthor | Arlov, Oystein | |
dc.contributor.coauthor | Rutsche, Dominic | |
dc.contributor.coauthor | Korayem, Maryam Asadi | |
dc.contributor.coauthor | Zenobi-Wong, Marcy | |
dc.contributor.department | KUTTAM (Koç University Research Center for Translational Medicine) | |
dc.contributor.department | School of Medicine | |
dc.contributor.kuauthor | Öztürk, Ece | |
dc.contributor.schoolcollegeinstitute | Research Center | |
dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
dc.date.accessioned | 2024-11-09T23:57:45Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Sulfated polysaccharides are ubiquitous in living systems and have central roles in biological functions such as organism development, cell proliferation and differentiation, cellular communication, tissue homeostasis, and host defense. Engineered sulfated polysaccharides (ESPs) are structural derivatives not found in nature but generated through chemical and enzymatic modification of natural polysaccharides, as well as chemically synthesized oligo- and polysaccharides. ESPs exhibit novel and augmented biological properties compared with their unmodified counterparts, mainly through facilitating interactions with other macromolecules. These interactions are closely linked to their sulfation patterns and backbone structures, providing a means to fine-tune biological properties and characterize structural-functional relationships by employing well-characterized polysaccharides and strategies for regioselective modification. The following review provides a comprehensive overview of the synthesis and characterization of ESPs and of their biological properties. Through the pioneering research presented here, key emerging application areas for ESPs, which can lead to novel breakthroughs in biomedical research and clinical treatments, are highlighted. | |
dc.description.indexedby | WOS | |
dc.description.indexedby | Scopus | |
dc.description.issue | 19 | |
dc.description.openaccess | YES | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.sponsorship | Norwegian Research Council through the "3DLife" project [269273/O30] | |
dc.description.sponsorship | Swiss National Science Foundation [315230_192656] | |
dc.description.sponsorship | 2232 International Fellowship for Outstanding Researchers Program of TuBTAK [118C238] | |
dc.description.sponsorship | TuBTAK D.R. and M.A.K. contributed equally to this work. The contributions of Oystein Arlov were supported by the Norwegian Research Council through the "3DLife" project (Grant No. 269273/O30). M.Z.-W. acknowledges the Swiss National Science Foundation (Grant No. 315230_192656) for her contributions to this review. E.o. benefits from the 2232 International Fellowship for Outstanding Researchers Program of TuBTAK (Project No. 118C238). However, the entire responsibility of the publication/paper belongs to the owner of the publication/paper. The financial support received from TuBTAK does not mean that the content of the publication is approved in a scientific sense by TuBTAK. Lastly, the authors would like to thank Dr. Elaheh Jooybar for her feedback on the manuscript. | |
dc.description.volume | 31 | |
dc.identifier.doi | 10.1002/adfm.202010732 | |
dc.identifier.eissn | 1616-3028 | |
dc.identifier.issn | 1616-301X | |
dc.identifier.quartile | Q1 | |
dc.identifier.scopus | 2-s2.0-85101844048 | |
dc.identifier.uri | https://doi.org/10.1002/adfm.202010732 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/15352 | |
dc.identifier.wos | 623175600001 | |
dc.keywords | Biopolymers | |
dc.keywords | Coagulation | |
dc.keywords | Immune system | |
dc.keywords | Sulfation | |
dc.keywords | Tissue engineering | |
dc.keywords | Embryonic stem-cells | |
dc.keywords | K5 capsular polysaccharide | |
dc.keywords | Endothelial growth-factor | |
dc.keywords | Water-soluble polysaccharides | |
dc.keywords | Bone morphogenetic protein-2 | |
dc.keywords | Human dermal fibroblasts | |
dc.keywords | Heparin-like compounds | |
dc.keywords | Herpes-simplex-virus | |
dc.keywords | In-vitro | |
dc.keywords | Molecular-weight | |
dc.language.iso | eng | |
dc.publisher | Wiley-V C H Verlag Gmbh | |
dc.relation.ispartof | Advanced Functional Materials | |
dc.subject | Chemistry | |
dc.subject | Physical chemistry | |
dc.subject | Nanoscience | |
dc.subject | Nanotechnology | |
dc.subject | Materials Science | |
dc.subject | Physics | |
dc.subject | Condensed Matter | |
dc.subject | Applied physics | |
dc.title | Engineered sulfated polysaccharides for biomedical applications | |
dc.type | Review | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Öztürk, Ece | |
local.publication.orgunit1 | SCHOOL OF MEDICINE | |
local.publication.orgunit1 | Research Center | |
local.publication.orgunit2 | KUTTAM (Koç University Research Center for Translational Medicine) | |
local.publication.orgunit2 | School of Medicine | |
relation.isOrgUnitOfPublication | 91bbe15d-017f-446b-b102-ce755523d939 | |
relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isOrgUnitOfPublication.latestForDiscovery | 91bbe15d-017f-446b-b102-ce755523d939 | |
relation.isParentOrgUnitOfPublication | d437580f-9309-4ecb-864a-4af58309d287 | |
relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | d437580f-9309-4ecb-864a-4af58309d287 |